The AI in Healthcare & Pharma Summit 2026 takes place November 17–18 at Hilton Boston Park Plaza. Organized by RE•WORK, the Boston event connects healthcare providers, pharmaceutical companies and AI practitioners working on the use of machine learning in clinical and research settings. These dates follow the organizer’s current announcement.
Clinical Workflows, Research and Governance
The announced themes include AI-assisted clinical workflows, data interoperability, personalized care, drug development and organizational readiness. Governance and validation are central considerations: an effective demonstration is only one part of introducing a system into a hospital, research team or pharmaceutical operation. The program brings together technical and operational perspectives on those challenges.
The current speaker roster includes Nirav Parikh of Mass General Brigham Healthcare, Shuja Khan of Roche, Naveen Pentakota of Kite Pharma and Anuvrat Chaturvedi of Gilead Sciences. Speakers from Optum, Bristol Myers Squibb, Vertex Pharmaceuticals, Novartis and BD also appear in the announced lineup.
Planning Your Boston Visit
The venue is Hilton Boston Park Plaza, 50 Park Plaza, Boston, MA 02116. The organizer’s venue page identifies the conference hotel, while Hilton provides the property’s official directions and guest information. Confirm any event-specific arrival details before travelling.
Review the summit schedule for the latest session arrangements, then use the official registration page to check ticket inclusions. Pass availability and program details can change, so the organizer’s booking terms should guide attendance plans.
Click to see more
Speakers
Nirav Parikh
Head of Enterprise Data and AI, Mass General Brigham Healthcare
Shuja Khan
Head of AI Strategy and Business Transformation, Roche
Naveen Pentakota
Director, Data Science, Kite Pharma
Anuvrat Chaturvedi
Senior Director, Data Science, Gilead Sciences
Marissa Seligman
VP, Clinical Data Optimization, Optum
Yunpeng Liu-Lupo
Senior Director, Analytical AI Clinical Development, Bristol Myers Squibb
Lily Xu
Director, Clinical Data Science, Vertex Pharmaceuticals
